Yokoyama, Takanori
Takehara, Kazuhiro
Sugimoto, Nao
Kaneko, Keika
Fujimoto, Etsuko
Okazawa-Sakai, Mika
Okame, Shinichi
Shiroyama, Yuko
Yokoyama, Takashi
Teramoto, Norihiro
Ohsumi, Shozo
Saito, Shinya
Imai, Kazuho
Sugano, Kokichi
Funding for this research was provided by:
The National Cancer Center Research and Development Fund (25-A-1 and 28-A-1)
Practical Research for Innovative Cancer Control (15ck0106097 h0102)
Program for Promoting Practical Applications of Genomic Medicine from the Japan Agency for Medical Research and Development (15cK0106168 h0201)
Article History
Received: 28 April 2017
Accepted: 8 May 2018
First Online: 21 May 2018
Ethics approval and consent to participate
: This study has been approved by the ethical review board of Shikoku Cancer Center.
: Written informed consent to publish the data was obtained from the patients.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.